The Claim

In adults with metabolic dysfunction-associated steatotic liver disease (MASLD) without type 2 diabetes, 12 weeks of matched weight loss achieved through either lifestyle intervention or liraglutide (1.8 mg/day) results in similar reductions in liver fat content (approximately 7.5%) and liver enzyme levels, indicating that weight loss itself is the primary driver of hepatic improvement.

Source: Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
68score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

In people with MASLD but without diabetes, losing the same amount of weight through diet and exercise or through liraglutide medication leads to similar decreases in liver fat and liver enzyme levels, suggesting that weight loss is the main factor improving liver health.

See the scientific wording

In adults with metabolic dysfunction-associated steatotic liver disease (MASLD) without type 2 diabetes, 12 weeks of matched weight loss achieved through either lifestyle intervention or liraglutide (1.8 mg/day) results in similar reductions in liver fat content (approximately 7.5%) and liver enzyme levels, indicating that weight loss itself is the primary driver of hepatic improvement.

Why this might work

When a person loses weight, fat cells release less fat into the bloodstream, and the liver makes less new fat from sugar. This reduces the amount of fat stored in the liver, improving liver health.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD

    In people with fatty liver but no diabetes, losing the same amount of weight—whether by eating less and exercising or by taking liraglutide—led to the same improvement in liver fat and liver health. This suggests it’s the weight loss itself, not the medicine, that fixes the liver.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.